TSHR and thyroid cancer: A very small subset of nodules was co-mutated with better characterized thyroid cancer driver mutations from the RAS family and BRAFV600E as previously described, and they were excluded from this analysis in favor of analyzing the risk of malignancy in ITN with isolated TSHR variants as detected by the Afirma XA (11, 20).